Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jinling Ma

A Novel Anti-Egfr mAb Ame55 With Lower Toxicity and Better Efficacy Than Cetuximab When Combined With Irinotecan

Journal of Immunology Research

English

Prediction of Perioperative Cardiac Events Through Preoperative NT-pro-BNP and cTnI After Emergent Non-Cardiac Surgery in Elderly Patients

PLoS ONE

Multidisciplinary

2015

English

Related publications

Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations

Experimental and Therapeutic Medicine

English

Assessment of 213Bi-Anti-Egfr MAb Treatment Efficacy in Malignant Cancer Cells With [1-13C]pyruvate and [18F]FDG

Scientific Reports

Multidisciplinary

2019

English

GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer

English

Significant Therapeutic Efficacy With Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer

Journal of Nuclear Medicine

English

Concomitant and Feasible Treatment With Dasatinib and the Anti-Egfr Antibody Cetuximab Plus Radiotherapy in a CML Patient With Multiple Squamous Neoplasias

English

Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules

Current Drug Metabolism

Clinical Biochemistry

Pharmacology

2011

English

When Two Is Better Than One

English

Skin Toxicity Ant Anti-Egfr-Therapy: A Mock Trouble for Elderly and Frail Patients With McRc

Annals of Hematology & Oncology

2018

English

A Novel Form of 4-1bbl Has Better Immunomodulatory Activity Than an Agonistic Anti-4-1bb Ab Without Ab-Associated Severe Toxicity

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jinling Ma

A Novel Anti-Egfr mAb Ame55 With Lower Toxicity and Better Efficacy Than Cetuximab When Combined With Irinotecan

Prediction of Perioperative Cardiac Events Through Preoperative NT-pro-BNP and cTnI After Emergent Non-Cardiac Surgery in Elderly Patients

Related publications

Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations

Assessment of 213Bi-Anti-Egfr MAb Treatment Efficacy in Malignant Cancer Cells With [1-13C]pyruvate and [18F]FDG

GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer

Significant Therapeutic Efficacy With Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer

Concomitant and Feasible Treatment With Dasatinib and the Anti-Egfr Antibody Cetuximab Plus Radiotherapy in a CML Patient With Multiple Squamous Neoplasias

Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules

When Two Is Better Than One

Skin Toxicity Ant Anti-Egfr-Therapy: A Mock Trouble for Elderly and Frail Patients With McRc

A Novel Form of 4-1bbl Has Better Immunomodulatory Activity Than an Agonistic Anti-4-1bb Ab Without Ab-Associated Severe Toxicity